IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4449
Positioning
Market Dominance
Manufacturing
Automobiles And Trucks
$18M
Peter Z. Wang
Cenntro Electric Group Limited designs and manufactures electric light and medium-duty commercial vehicles in Europe, North America, and Asia. The company was founded in 2013 and is headquartered in Freehold, New Jersey.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$CENN Cenntro Inc. | 31 | 38 | 31 | 5 | - | - | -41.0% | -27.7% | 10.3% | -156.8% | -154.9% | -45.1% | 0.0% | 48.0x | $18M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Cenntro Inc. (CENN) receives a "Avoid" rating with a composite score of 31.2/100. It ranks #4449 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Peter Z. Wang
Chief Executive Officer
Labor Force
210
38
36
29
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for CENN
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Average quality profile
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for CENN.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
ROIC -138.1% vs WACC 5.9% (spread -144.0%)
GM 10% vs sector 43%, OM -157% vs sector 1%
Capital turnover 1.16x, R&D intensity 14.9%
Rev growth -45%, 7yr history
Interest coverage -61.0x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Cenntro Inc. with an Avoid rating, assigning a composite score of 31.2/100 and 1 out of 5 stars. Ranked #4449 of 7,333 stocks, CENN falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
CENN's quality score of 38/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -41.0% (sector avg: -2.5%), gross margins of 10.3% (sector avg: 42.5%), net margins of -154.9% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 31/100, CENN appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 0.14x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
Cenntro Inc.'s investment score of 36/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -45.1% vs. a sector average of 5.9% and a return on assets of -27.7% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Cenntro Inc. is experiencing notably weak momentum with a score of just 5/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -45.1% year-over-year, while a beta of 1.35 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
CENN's stability score of 29/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 1.35 and a debt-to-equity ratio of 48.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 51/100 for CENN suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include above-average market sensitivity (beta: 1.35), elevated leverage (D/E: 48.00x), micro-cap liquidity risk. With a $18M market cap (micro-cap), Cenntro Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Cenntro Inc. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4449 of 7,333 overall (39th percentile). Key comparisons include ROE of -41.0% trailing the -2.5% sector median and operating margins of -156.8% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While CENN currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (5) would have the largest impact on the composite score.
ROE 1555% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 76% BELOW SECTOR MEDIAN
Op. Margin 12251% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Cenntro Inc. (CENN) as Avoid with a composite score of 31.2/100 at a current price of $0.12. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in quality (38th percentile) and investment (36th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (5th percentile) and stability (29th percentile) tempers our overall conviction. We assign a No Moat rating (19/100), High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Cenntro Inc. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 31.2/100 places it at rank #4449 in our full 7,333-stock universe. At $18M in market capitalization, Cenntro Inc. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -45% combined with momentum at the 5th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 10% (-32.2pp vs sector) narrow to operating margins of -157% (-158.0pp vs sector) and net margins of -154.9%, yielding a gross-to-net conversion rate of -1506%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $0.12, Cenntro Inc. is trading at a premium to fundamental value. Our value factor score of 31/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 0.1x, P/S of 0.3x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock may offer contrarian value if near-term headwinds prove transitory — the current weakness in factor scores may reverse if business fundamentals stabilize.
The Avoid rating (composite 31.2/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -45% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -154.9% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (5th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a High uncertainty rating to Cenntro Inc.. Key risk factors include elevated market sensitivity (beta of 1.35), current negative profitability (net margin -154.9%), below-average price stability (29th percentile). The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 1.35); current negative profitability (net margin -154.9%); below-average price stability (29th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 29th percentile and quality factor at the 38th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate Cenntro Inc.'s capital allocation as Poor. Key concerns include low returns on equity (-41.0%), negative profitability, weak asset returns (ROA -27.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Cenntro Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Cenntro Inc. receives a Avoid rating with a composite score of 31.2/100 (rank #4449 of 7,333). Our quantitative framework assigns a No Moat (19/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 28/100.
Our analysis does not support a constructive view on Cenntro Inc. at this time. The combination of limited competitive advantages, high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Cenntro Inc. a meaningful economic moat, scoring 19/100 on our composite assessment. The ROIC-WACC spread of -144.0% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, financial resilience, reached only 8.7/20.
The strongest moat sources are financial resilience (8.7/20) and reinvestment efficiency (6.8/20). Interest coverage -61.0x. Capital turnover 1.16x, R&D intensity 14.9%. These pillars form the core of Cenntro Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (0/20) and margin superiority (0.5/20). ROIC -138.1% vs WACC 5.9% (spread -144.0%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Cenntro Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include declining revenues (-45%) that pressure the earnings outlook. The margin cascade from 10% gross to -157% operating to -154.9% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 38th percentile.
The margin profile shows gross margins of 10%, operating margins of -157%, net margins of -154.9%. Return metrics include ROE of -41.0% and ROA of -27.7%. Relative to the Manufacturing sector, gross margins are 32.2 percentage points below the sector median of 43%, and ROE of -41.0% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 48%, revenue growth of -45%. The sector median D/E is 0%, putting Cenntro Inc. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
ISELIN, N.J., October 24, 2025--Cenntro Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

Gainers Prestige Wealth Inc. (NASDAQ: PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial public offering of 1 million shares of common stock at a price of $5 per share. Gorilla Technology Group Inc. (NASDAQ: GRRR) jumped 68.9% to $3.52 after the company signed a $270 million contract with the Government of Egypt to implement a Smart Government Security Convergence solution. Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares climbed 64.8% to $0.3576 after dropping over 5% on Thursday. Castle Biosciences, Inc. (NASDAQ: CSTL) shares surged 42.2% to $18.89. Castle Biosciences will present new DecisionDx-SCC and DecisionDx-melanoma data at the American Head & Neck Society's International Conference on head and neck cancer. SCWorx Corp. (NASDAQ: WORX) gained 28.8% to $0.3780. Near Intelligence, Inc. (NASDAQ: NIR) climbed 27.6% to $1.5182. Benchmark initiated coverage on Near Intelligence with a Speculative Buy rating and announced a price target of $3. CareDx, Inc (NASDAQ: CDNA) climbed 19.7% to $10.04. The Beachbody Company, Inc. (NYSE: BODY) gained 17.2% to $0.3749 after dropping around 24% on Thursday. NuZee, Inc. (NASDAQ: NUZE) climbed 15.6% to $10.57 after the company announced it entered into a five-year global licensing agreement with Stone Brewing. TMC the metals company Inc. (NASDAQ: TMC) rose 15.5% to $2.3450. Society Pass Incorporated (NASDAQ: SOPA) jumped 14.7% to $0.5389. Society Pass subsidiary, NextGen Retail, will acquire Indonesia's PT Inetindo Infocom for $1.85 ...

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect. Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 90.1% to $0.3089 after the company reported a $30 million private placement of common stock led by Accelmed Partners. Jounce Therapeutics, Inc. (NASDAQ: JNCE) climbed 61.3% to $1.19 after Gilead Sciences announced plans to acquire all remaining rights to the company's Immunotherapy GS-1811, an anti-CCR8 antibody, for $67 million. Gorilla Technology Group Inc. (NASDAQ: GRRR) rose 51% to $6.80 after the company announced it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal. Innovative Eyewear, Inc. (NASDAQ: LUCY) gained 44.6% to $1.33 after the company announced a multi-year, global licensing agreement with Authentic Brands Group for Eddie Bauer smart eyewear. Unico American Corporation (NASDAQ: UNAM) jumped 35.2% to $1.5413. Pagaya Technologies Ltd.. (NASDAQ: PGY) climbed 24.3% to $1.2801 after climbing 23% on Tuesday. Instil Bio, Inc. (NASDAQ: TIL) gained 22.8% to $0.5902. Smart for Life, Inc. (NASDAQ: SMFL) gained 22.7% to $0.2550. Heart Test Laboratories, Inc. (NASDAQ: HSCS) surged 22.2% to $0.99. Cosmos Health Inc. (NASDAQ: COSM) shares climbed 20.1% to $5.26. Cenntro Electric Group Limited (NASDAQ: CENN) rose 20.1% to $0.4720. Virgin Orbit Holdings, Inc. (NASDAQ: VORB) gained 13.7% to $1.8650. Miromatrix Medical Inc. (NASDAQ: MIRO) shares rose 12.8% to $2.8220. TuSimple Holdings Inc. (NASDAQ: TSP) gained 11.7% to $1.52. Aclarion, Inc. (NASDAQ: ACON) rose 11.6% to $0.45. GlycoMimetics, Inc. (NASDAQ: GLYC) gained 10.7% to $2.48. Mount Rainier Acquisition Corp. (NASDAQ: RNER) shares rose 10.6% to $11.51. Lion Group Holding Ltd. (NASDAQ: LGHL) ...

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. IsoPlexis Corporation (NASDAQ: ISO) rose 82.4% to $1.2598. Berkeley Lights announced plans to acquire IsoPlexis in all-stock transaction at $57.8 million. AMC Entertainment Holdings, Inc. (NYSE: APE) gained 77% to $1.21. AMC Entertainment Holdings Inc (NYSE: AMC) announced an equity capital raise and a debt for equity exchange. The company also proposed a vote to convert AMC Preferred Equity Units into common shares and enact a reverse stock split. ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) climbed 69% to $5.05 after the company announced it has entered into a clinical development collaboration for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer and agreed to sell about 5.38 million of its common shares at a price of $4.65 per share to Pfizer for proceeds of approximately $25 million. ProQR Therapeutics N.V. (NASDAQ: PRQR) shares jumped 61% to $2.6400 after the company, along with Eli Lilly, announced the expansion of their licensing and collaboration agreement of new genetic medicines. ProQR will receive an upfront payment of $75 million, plus an equity investment. E-Home Household Service Holdings Limited (NASDAQ: EJH) gained 27.8% to $0.90. Scopus BioPharma Inc. (NASDAQ: SCPS) climbed 25% to $0.10. Alvotech (NASDAQ: ALVO) gained 25.8% to $10.44 after the company issued an update on U.S. regulatory status of AVT02, the company’s proposed high-concentration, interchangeable biosimilar to Humira. Rekor Systems, Inc. (NASDAQ: REKR) gained 23.3% to $1.1482. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 20.4% to $1.65. Edesa Biotech recently received Fast Track designation from the FDA for its monoclonal antibody candidate, EB05. Polished.com Inc. (NYSE: POL) surged 19.3% to $0.68 after the company announced internal investigation results, corporate updates and the board of directors' remedial actions. China Index Holdings Limited (NASDAQ: CIH) jumped 17.5% to $0.8930. China Index Holdings entered into definitive agreement for going-private transaction. Optical Cable Corporation (NASDAQ: OCC) jumped 16.3% to $4.1527 after the company reported Q4 sales results were higher ...

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. IsoPlexis Corporation (NASDAQ: ISO) rose 59.4% to $1.10 in pre-market trading. Berkeley Lights announced plans to acquire IsoPlexis in all-stock transaction at $57.8 million. ORIC Pharmaceuticals, Inc (NASDAQ: ORIC) shares rose 46.3% to $4.39 in pre-market trading after the company reported a clinical development collaboration with Pfizer for ORIC-533 in multiple myeloma and announced a concurrent $25 million equity investment by Pfizer. OceanPal Inc. (NASDAQ: OP) rose 26.3% to $2.19 in pre-market trading after dipping 88% on Wednesday. Fangdd Network Group Ltd. (NASDAQ: DUO) rose 20.8% to $0.93 in pre-market trading. Swvl Holdings Corp. (NASDAQ: SWVL) rose 19.8% to $0.1198 in pre-market trading after dropping 23% on Wednesday. Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 15.2% to $1.74 in pre-market trading after jumping 28% on Wednesday. MicroAlgo Inc. (NASDAQ: MLGO) shares rose 12.4% to $1.91 in pre-market trading after gaining 6% on Wednesday. WeTrade Group, Inc. (NASDAQ: WETG) rose 12.4% to $0.2720 in pre-market trading after dropping 37% on Wednesday. DatChat, Inc. (NASDAQ: DATS) rose 11.4% to $0.44 in pre-market trading after gaining 12% on Wednesday. GoHealth, Inc. (NASDAQ: GOCO) rose 11.4% to $15.00 in ...
Above 50MA
37.18%
Net New Highs
+51081